Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRADIMED CORP Director's Dealing 2024

Jun 4, 2024

32324_dirs_2024-06-04_a436f665-ff85-47de-8a00-66a53d94bfcf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2024-06-03

Reporting Person: ALLEN MONTY K (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-06-03 Common Stock S 1947 $43.3654 Disposed 18053 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $43.17 to $43.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.